Cancer Research and Treatment Fund Inc
CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.
Cancer Research and Treatment Fund Inc at a glance
In short: Cancer Research and Treatment Fund Inc gave $521K across 1 grant in 2024 (avg $521K), mostly in New York. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $521,050
- -0.7% vs 2023
- Grants made (2024)
- 1
- -50.0% vs 2023
- Average grant
- $521,050
- +98.7% vs 2023
- Median grant
- $521,050
- Total assets
- $15,194,701
- +10.5% vs 2023
- Primary geography
- New York (100% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated September 2026.
Who Cancer Research and Treatment Fund Inc funds
How this funder distributes its grants
Top Recipients
Top recipient in 2024
The largest 2024 recipient was Weill Cornell Medical College ($521K).
Grant Size Distribution
7 grants across all recorded years
The most common grant size was in the $250–500K range: 3 grants of 7 (43%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
Share of the 2024 grant dollars on its one itemized grant.
States
Cities
How Cancer Research and Treatment Fund Inc gives
- Giving grew 39% from 2021 to 2024. Method
From the foundation's IRS Form 990 filings. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $375K (2021) to $525K (2023). In 2024 it made 1 grant totaling $521K.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Weill Cornell Medical College New York, NY | Research- Myeloproliferative Neopla | $521,050 |
Ready to take the next step with Cancer Research and Treatment Fund Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $15,194,701 | $1,146,870 | $1,004,872 | $521,050 | 1 | $510,544 |
| 2023 | $13,748,310 | $1,026,414 | $1,011,255 | $524,500 | 2 | $382,378 |
| 2022 | $12,581,316 | $573,018 | $957,125 | $483,500 | 1 | $74,174 |
| 2021 | $14,862,676 | $1,096,322 | $810,847 | $375,000 | 1 | $611,059 |
| 2020 | $13,981,569 | $1,420,266 | $808,875 | $388,000 | 2 | $731,972 |
About Cancer Research and Treatment Fund Inc
Based on IRS filings
Cancer Research and Treatment Fund Inc is a public charity, based in New York, NY. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $15.2M in total assets. In 2024, it awarded 1 grant totaling $521K. Net investment income was $511K.
Leadership & Key People
Officers and directors from IRS filings
Cancer Research and Treatment Fund Inc's 2024 filing lists 18 officers; 1 of 18 officers listed in 2024 is compensated.
Officers on the 2024 filing
Richard Tsilver MD
Director
Trustee → Director, 2022
On filings since 2020
40 hrs/week
$120K (2020) → $120K (2024)
Adam Silver
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Aj Shiekman
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Amanda Johns Perez
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Anne Templeton
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
David Boule
Director
Trustee → Director, 2022
On filings since 2020
3 hrs/week
No compensation reported
Jeffrey Puglisimd
Director
Trustee → Director, 2022
On filings since 2020
No compensation reported
KASIA McCORMICK
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Maria Brisbane
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Michael C. Kempner
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Nelson Boxer
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Richard Rose
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Terry Hermanson
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Thomas Silver
Director
Trustee → Director, 2022
On filings since 2020
3 hrs/week
No compensation reported
Tim Silver
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Todd Shaw
Director
Trustee → Director, 2022
On filings since 2020
1 hr/week
No compensation reported
Caleb Sexton
Director
New on the 2024 filing
1 hr/week
No compensation reported
Rajesh Shah
Director
New on the 2024 filing
1 hr/week
No compensation reported
Former officers (3)
- Former: Bharat Shah (2020–2023) — Director
- Former: Joseph N. Aimi (2020–2022) — Director
- Former: Keith Civil (2020–2021) — Trustee
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $120K, to Richard Tsilver MD (Director).
Frequently asked questions about Cancer Research and Treatment Fund Inc
How much does Cancer Research and Treatment Fund Inc give each year?
Cancer Research and Treatment Fund Inc gave $521K across 1 grant in 2024, according to its 2024 IRS Form 990. In 2023 it gave $525K across 2 grants.
How large is Cancer Research and Treatment Fund Inc?
Cancer Research and Treatment Fund Inc reported $15.2M in total assets on its 2024 IRS Form 990. Its revenue that year was $1.1M.
Where does Cancer Research and Treatment Fund Inc operate?
Cancer Research and Treatment Fund Inc has awarded grants in New York.
What is Cancer Research and Treatment Fund Inc's EIN?
Cancer Research and Treatment Fund Inc's EIN (Employer Identification Number) is 13-6272085. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS October 25, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS September 26, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS September 7, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS September 13, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS September 8, 2025)
- IRS filings on file for fiscal years 2020–2024
Explore Open Grants
Browse active grant opportunities in Cancer Research and Treatment Fund Inc's focus areas in our free grants database
Similar Funders
Similar funders in New York
The Ford Foundation
New York, NY
The Ford Foundation funds organizations and initiatives working to reduce inequality and advance social justice, including work on civic engagement, civil rights, climate justice, disability rights, and technology and society. In 2024, its grants ranged from $45 to $15 million, with a median of $100,000, supporting work in the U.S. and internationally. It says most grants are identified by the foundation and it does not accept unsolicited proposals by mail, email, or phone; limited opportunities may be offered separately.
Assets
$17.5B
Grants
4,007
Total Given
$844.7M
The New York Community Trust
New York, NY
The New York Community Trust funds nonprofit programs in areas such as arts, education, health, the environment, workforce development, and youth development, including projects that improve services, build organizational capacity, or advance policy and systems change. Its competitive grants mainly serve New York City, Long Island, and Westchester, with some national and international environmental funding; the 2024 median grant was $20,000. The profile does not state whether it accepts unsolicited requests.
Assets
$3.5B
Grants
2,748
Total Given
$193.8M
The Simons Foundation Inc
New York, NY
The Simons Foundation funds research and public engagement in mathematics and the physical, life, autism, and neuroscience sciences. In 2024, it made 1,727 grants, with a median award of $72,000 and amounts ranging from $1,480 to $20 million, supporting organizations in the U.S. and internationally. It states that it funds only preselected charitable organizations and does not accept unsolicited requests.
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Local Initiatives Support Corporation
New York, NY
LISC funds affordable housing, community development, small businesses, and related efforts that strengthen inclusive communities, providing grants as well as loans, equity, and technical assistance across the country. Its 2024 grants had a median award of $40,000, though amounts varied widely. Application access is program-specific: for its Rhode Island child care facilities planning grants, applicants are instructed to consult program staff before submitting a request.
Assets
$1.6B
Grants
1,119
Total Given
$102.8M
Wellspring Philanthropic Fund Inc
New York, NY
Wellspring Philanthropic Fund supports human rights and social and economic justice, including work on climate, the environment, civic engagement, and Jewish causes, in the United States and internationally. Its 2024 grants had a median of $200,000, with amounts ranging from $500 to $9.75 million. It funds only preselected organizations and does not accept unsolicited requests; it plans to end grantmaking by the end of 2028.
Assets
$134.4M
Grants
1,101
Total Given
$326.0M
More Funders in New York
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from Cancer Research and Treatment Fund Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Cancer Research and Treatment Fund Inc down — hundreds of funders to go?